Induced expression of fusion protein taking TTC as neuronal cell targeting gene

A neuron cell and fusion protein technology, which is applied in the direction of targeting specific cell fusion, fusion with toxin, fusion with spectrum/fluorescence detection, etc., can solve the problem of difficulty in constructing recombinant virus vector, cumbersome operation, potential risks to be determined, etc. question

Pending Publication Date: 2022-03-11
HUBEI UNIV OF SCI & TECH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] 1. The huge genome of HSV-1 makes it difficult to construct recombinant viral vectors by conventional methods
[0009] 2. This method is cumbersome to operate, low in efficiency of recombination, time-consuming and labor-intensive
[0010] 3. However, its potential risks are still to be determined. HSV has neurocytotoxic effects and immune responses, which can cause more obvious local inflammation and necrosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Induced expression of fusion protein taking TTC as neuronal cell targeting gene
  • Induced expression of fusion protein taking TTC as neuronal cell targeting gene
  • Induced expression of fusion protein taking TTC as neuronal cell targeting gene

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0034] The following are specific embodiments of the present invention and in conjunction with the accompanying drawings, the technical solutions of the present invention are further described, but the present invention is not limited to these embodiments.

[0035]Induced expression of a fusion protein composed of three gene fragments of mitochondrial outer membrane protein FUNDC1, tetanus avirulent C-terminal fragment TTC and green fluorescent protein EGFP in Escherichia coli BL21(DE3). The three gene fragments are connected together to perform their own functions. First, the tetanus avirulent C-terminal fragment TTC is used to target nerve cells because of its neuroinvasiveness. The tetanus avirulent C-terminal fragment TTC can carry our target gene FUNDC1 and transport it to nerve cells. After the green fluorescent protein EGFP enters the nerve cells, it can emit green fluorescence in the nerve cells. It is convenient for us to observe with the naked eye under a fluorescent...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides induced expression of a fusion protein taking TTC as a neuronal cell targeting gene, and belongs to the technical field of biological medicines. The method comprises the following steps: 1, respectively designing corresponding primers for base sequences of mitochondrial outer membrane protein FUNDC1, tetanus heavy chain C-terminal non-toxic fragment TTC and green fluorescent protein EGFP, and then respectively carrying out PCR (Polymerase Chain Reaction) amplification; 2, recovering the genes of the three segments in the step 1, connecting the genes with a PET-32a (+) expression vector carrying an HIS (6 * his) label, and then transforming escherichia coli DH5alpha; 3, extracting plasmids for sequencing through positive clone screening; 4, transferring the plasmids which are correctly sequenced into escherichia coli BL21 (DE3), and carrying out mass expression and purification, so as to obtain the TTC-mFunddc1-EGFP fusion protein with relatively high concentration; the neuroinvasiveness of a tetanus non-toxic C-terminal fragment TTC in the TTC-mFunddc1-EGFP fusion protein is utilized, and the tetanus non-toxic C-terminal fragment TTC is targeted to nerve cells. According to the invention, the mouse FUNDC1 fusion protein with targeted nerve cells can be obtained.

Description

technical field [0001] The invention belongs to the technical field of biomedicine and relates to the induced expression of a fusion protein using TTC as a neuron cell targeting gene. Background technique [0002] Diabetes mellitus (DM) is a major global public health problem. The incidence of diabetes is increasing year by year, and it has become the third largest non-communicable disease in developed countries after cardiovascular and tumors. According to epidemiological research surveys, the total number of diabetes patients in the world is about 425 million, and my country's diabetes patients account for about 1 / 3 of the world. With the improvement of living standards and changes in lifestyle, the incidence of diabetes is increasing. Diabetic neuropathy is an important complication of diabetes, and it has various forms, mainly including peripheral neuropathy and autonomic neuropathy, etc. These lesions seriously affect the quality of life of diabetic patients, and oxida...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K19/00C07K1/22C12N15/62C12N15/70
CPCC07K14/47C12N15/70C07K2319/21C07K2319/55C07K2319/60C07K2319/33C12N2800/101
Inventor 余开湖欧阳昌汉谢紫洁
Owner HUBEI UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products